The Future of Wound Care Is Synthetic: Mirragen's Breakthrough for Hard-to-Heal Wounds

Join Frank & Lizzie on The Frank & Lizzie Show as they explore the groundbreaking advances in wound care with Mirragen, a borate-based bioactive glass fiber matrix (BBGFM) from ETS. Featuring exclusive insights from AJ Ford, CEO of ETS, and Dr. Marc Gitterle, a leading wound care expert, this episode highlights the latest results from Mirragen’s second randomized controlled trial (RCT) focused on diabetic foot ulcers (DFUs). Discover how synthetic materials like Mirragen are transforming healing outcomes, accelerating recovery times, and offering cost-effective, versatile treatment options. Whether you're a healthcare provider or simply interested in medical innovation, this episode is packed with compelling data, clinical case studies, and expert opinions. Don’t miss this deep dive into the future of wound care!

Visit www.ets123.com for more information or visit https://onlinelibrary.wiley.com/doi/10.1111/iwj.70763?utm_source=chatgpt.com for the RCT.